Fludarabine/Cyclophosphamide/Rituxan is an effective regimen for non-myeloablative allogeneic stem cell transplantation (SCT) for lymphoid malignancies.

被引：0
|
作者：
Berkahn, LC [1 ]
Simpson, DR [1 ]
Raptis, A [1 ]
Klingemann, HG [1 ]
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5274
引用
收藏
页码：352B / 352B
页数：1
相关论文
共 50 条
  • [41] Unrelated and sibling allogeneic hematopoietic stem cell transplantation (HSCT) in patients with advanced hematological malignancies by using non-myeloablative conditioning regimen.
    Roemer, E
    Kiehl, MG
    Guenzelmann, S
    Rajewski, A
    Kirsten, D
    Fauser, AA
    Basara, N
    BLOOD, 2000, 96 (11) : 782A - 782A
  • [42] Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities
    Pizzola, Christopher J.
    Cioccio, Joseph
    Rakszawski, Kevin L.
    Nickolich, Myles
    Ehmann, W. Christopher
    Rybka, Witold B.
    Wirk, Baldeep
    Naik, Seema
    Zheng, Hong
    Silar, Brooke
    Shike, Hiroko
    Zhou, Shouhao
    Mineishi, Shin
    Minagawa, Kentaro
    Claxton, David F.
    BONE MARROW TRANSPLANTATION, 2022, 57 (11) : 1743 - 1745
  • [43] Treatment of multiple myeloma with an allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen
    Kmonicek, M
    Zak, P
    Jebavy, L
    Maisnar, V
    Maly, J
    BONE MARROW TRANSPLANTATION, 2003, 31 : S86 - S86
  • [44] Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.
    Weng, Jianyu
    Du, Xin
    Wu, Suijin
    Lu, Zesheng
    Luo, Chengwei
    Guo, Rong
    Zhong, Liye
    She, Miaorong
    Deng, Chengxin
    Ling, Wei
    Zou, Xiaoli
    Li, Qunhua
    Lin, Wei
    Huang, Zhixin
    BLOOD, 2009, 114 (22) : 472 - 472
  • [45] Favorable Outcome in Patients with Lymphoid Malignancies Following Allogeneic Stem Cell Transplantation Using Fludarabine and Treosulfan As the Preparative Regimen
    Yerushalmi, Ronit
    Shimoni, Avichai
    Shem-Tov, Noga
    Volchek, Yulia
    Avigdor, Abraham
    Nagler, Arnon
    BLOOD, 2012, 120 (21)
  • [46] A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients
    Tsirigotis, Panagiotis
    Bitan, Reuven Or Menachem
    Resnick, Igor B.
    Samuel, Simcha
    Ackerstein, Aliza
    Elad, Sharon
    Gesundheit, Benjamin
    Zilberman, Irina
    Miron, Svetlana
    Leubovic, Alexander
    Slavin, Shimon
    Shapira, Michael Y.
    HAEMATOLOGICA, 2006, 91 (06) : 852 - 855
  • [47] Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myeloablative conditioning regimen
    Ungkanont, A
    Mongkonsritrakoon, W
    Jootar, S
    Srichaikul, T
    BONE MARROW TRANSPLANTATION, 2000, 26 (12) : 1351 - 1354
  • [48] Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities
    Christopher J. Pizzola
    Joseph Cioccio
    Kevin L. Rakszawski
    Myles Nickolich
    W. Christopher Ehmann
    Witold B. Rybka
    Baldeep Wirk
    Seema Naik
    Hong Zheng
    Brooke Silar
    Hiroko Shike
    Shouhao Zhou
    Shin Mineishi
    Kentaro Minagawa
    David F. Claxton
    Bone Marrow Transplantation, 2022, 57 : 1743 - 1745
  • [49] Allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen for malignant lymphoma.
    Nagler, A
    Or, R
    Naparstek, E
    Varadi, G
    Slavin, S
    BONE MARROW TRANSPLANTATION, 1999, 23 : S23 - S23
  • [50] Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myeloablative conditioning regimen
    A Ungkanont
    W Mongkonsritrakoon
    S Jootar
    T Srichaikul
    Bone Marrow Transplantation, 2000, 26 : 1351 - 1354
12345